Medical News

RSS

AACR to host fourth International Conference on Molecular Diagnostics

The American Association for Cancer Research will host its Fourth AACR International Conference on Molecular Diagnostics in Cancer Therapeutic Development from Sept. 27-30, 2010, at the Sheraton Denver Downtown in Denver, Colo.

22 Sep 2010

Gen-Probe submits PMA to FDA for PROGENSA PCA3 assay

Gen-Probe announced today that the Company has submitted a Premarket Approval Application (PMA) to the US Food and Drug Administration (FDA) for its PROGENSA® PCA3 assay, a new molecular test that may help determine the need for repeat biopsies in men suspected of having prostate cancer.

22 Sep 2010

UC researcher receives NIDA’s Avant-Garde Award for cocaine addiction research

A University of Cincinnati (UC) researcher will receive $2.5 million over five years from the National Institute on Drug Abuse (NIDA) to support his work on a potential immunotherapy for cocaine addiction.

22 Sep 2010

Prevalence of periodontal disease in US higher than originally estimated

The prevalence of periodontal disease in the United States may be significantly higher than originally estimated. Research published in the Journal of Dental Research from the Centers for Disease Control and Prevention (CDC) and the American Academy of Periodontology (AAP) suggests that the prevalence of periodontal disease may have been underestimated by as much as 50 percent. The implication is that more American adults may suffer from moderate to severe gum disease than previously thought.

22 Sep 2010

Pancreas releases new NANETS guidelines on rare group of cancers

Neuroendocrine tumors (NETs) are a group of rare cancers that pose unique challenges in diagnosis and treatment. In a recent issue of Pancreas, official journal of the American Pancreatic Association, presents the newly developed consensus guidelines of the North American Neuroendocrine Tumor Society (NANETS).

22 Sep 2010

FDA guides Apricus Bio on RayVa's approvability for Raynaud's syndrome secondary to scleroderma

Apricus Biosciences, backed by a revenue-generating CRO business and seeking to leverage its multi-route NexACT® drug delivery technology and internal pipeline through out-licensing partnerships, announced today that the U.S. Food and Drug Administration (FDA) has provided guidance on the clinical requirements for assessing the approvability of RayVa for the treatment of Raynaud's syndrome secondary to scleroderma.

22 Sep 2010

Study: College women with heavy roommates gain less weight during freshman year

A new University of Michigan study finds that college women with roommates who weigh more than average gain less weight during their freshman year than women with slimmer roommates: half a pound versus 2.5 pounds.

22 Sep 2010

NIDA's Avant-Garde Awards support novel approaches for treating tobacco and cocaine addiction

A potential immunotherapy, a new gene therapy, an enzyme inhibitor, and a compound originally isolated from a Chinese herb are among the latest approaches scientists are proposing to treat addiction.

22 Sep 2010

Dr. Shlomo Melmed awarded 9th Endocrine Regulation Prize of the Fondation Ipsen

The international jury under the presidency of Professor Iain Robinson (National Institute for Medical Research, London, UK) awarded today the 9th Endocrine Regulation Prize of the Fondation Ipsen (20.000€) to Dr. Shlomo Melmed (Cedars-Sinai Medical Center, Los Angeles, USA) during the annual congress of the ENEA (European NeuroEndocrine Association) in Liège (Belgium), for his translational approach to endocrinology. Shlomo Melmed is an internationally recognized endocrinologist and an authority on pituitary medicine.

22 Sep 2010

New, easy-to-use system puts 'Radiology in the palm of your hand'

Physicians now have access to real time radiology services virtually anywhere, anytime. The new Virtual Viewbox- (patent pending) is a portable interface system that delivers images, electronic medical records (EMR), and specialist consultation to physicians using any internet-ready device.

22 Sep 2010

Mylan obtains temporary restraining order against Apotex and GlaxoSmithKline

Mylan Inc. today obtained a temporary restraining order from the U.S. District Court for the District of New Jersey that prohibits Apotex from "using, offering to sell, selling or shipping or otherwise launching … or importing" all three strengths of a generic version of GlaxoSmithKline's Paxil CR, Paroxetine Hydrochloride (HCl) Extended-release (ER) Tablets, 12.5 mg, 25 mg and 37.5 mg.

22 Sep 2010

ACP releases updated resource guide on health care reform

An updated practical resource guide for internists on the health care reform law adopted last March 23, the Patient Protection and Affordable Care Act (PPACA), was released today by the American College of Physicians (ACP).

22 Sep 2010

Islamic Relief USA provides $20 million medical aid to Pakistan

Islamic Relief USA (IR USA), a non-profit relief and development organization based in metro-D.C., announced today that it has delivered a $20 million aid shipment of medicine to Pakistan.

22 Sep 2010

U.S. community health centers receive $500,000 grant to increase access to quality healthcare

The GE Foundation - the philanthropic organization of GE - announced today the award of $500,000 in total to two Baltimore-based community health centers in an effort to help increase access to quality healthcare across the United States. As part of the GE Developing HealthTM program, these grants will support Chase Brexton Health Services and People's Community Health Centers, Inc. in providing increased access to healthcare in their respective communities.

22 Sep 2010

Masimo's noninvasive SpMet provides measurements comparable to invasive methemoglobin testing

Masimo announced today that a new clinical study published in Anesthesia & Analgesia demonstrates that Masimo noninvasive and continuous methemoglobin (SpMet®) measurements provide a high degree of agreement in measurements with corresponding laboratory values of methemoglobin obtained by invasive methemoglobin testing. In addition, the authors concluded that SpMet could facilitate early diagnosis and treatment of methemoglobinemia during high-risk procedures.

22 Sep 2010

JHS conference focuses on future research directions to eliminate health disparities

The tenth anniversary of the Jackson Heart Study (JHS) will be observed on Sept. 23-24 in Jackson, Mississippi. The JHS is the largest study in history to investigate genetic factors that affect high blood pressure, heart and lung disease, stroke, diabetes, and other important diseases in African-Americans.

22 Sep 2010

MIDAS researchers continue to model how H1N1 may spread

As the United States prepares for the upcoming flu season, a group of researchers supported by the National Institutes of Health continues to model how H1N1 may spread.

22 Sep 2010

Synthetic lethality boosts effectiveness of molecularly targeted therapies against tumors

Molecularly targeted therapies can reduce tumors rapidly. However, not all tumors respond to the drugs, and even those that do often develop resistance over time. Looking for a way to combat the problem of resistance, researchers at Fox Chase Cancer Center hypothesized that hitting already weakened cancer cells with a second targeted agent could kill them-but only if it was the right second agent.

22 Sep 2010

Boston Scientific reports positive data from PLATINUM Element Stent quantitative coronary angiography study

Boston Scientific Corporation today announced data from its PLATINUM QCA study, which is designed to evaluate the Company's PROMUS Element™ Everolimus-Eluting Platinum Chromium Coronary Stent. The results provided 30-day and nine-month clinical outcomes and nine-month quantitative coronary angiography (QCA) and intravascular ultrasound (IVUS) data supporting the safety and efficacy of the PROMUS Element Stent.

22 Sep 2010

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Dutch biopharmaceutical company Crucell N.V. and the Aeras Global TB Vaccine Foundation today announced the start of a Phase II clinical trial in infants of the jointly developed tuberculosis (TB) vaccine candidate, AERAS-402/Crucell Ad35.

22 Sep 2010

Medical News

AACR to host fourth International Conference on Molecular Diagnostics

Gen-Probe submits PMA to FDA for PROGENSA PCA3 assay

UC researcher receives NIDA’s Avant-Garde Award for cocaine addiction research

Prevalence of periodontal disease in US higher than originally estimated

Pancreas releases new NANETS guidelines on rare group of cancers

FDA guides Apricus Bio on RayVa's approvability for Raynaud's syndrome secondary to scleroderma

Study: College women with heavy roommates gain less weight during freshman year

NIDA's Avant-Garde Awards support novel approaches for treating tobacco and cocaine addiction

Dr. Shlomo Melmed awarded 9th Endocrine Regulation Prize of the Fondation Ipsen

New, easy-to-use system puts 'Radiology in the palm of your hand'

Mylan obtains temporary restraining order against Apotex and GlaxoSmithKline

ACP releases updated resource guide on health care reform

Islamic Relief USA provides $20 million medical aid to Pakistan

U.S. community health centers receive $500,000 grant to increase access to quality healthcare

Masimo's noninvasive SpMet provides measurements comparable to invasive methemoglobin testing

JHS conference focuses on future research directions to eliminate health disparities

MIDAS researchers continue to model how H1N1 may spread

Synthetic lethality boosts effectiveness of molecularly targeted therapies against tumors

Boston Scientific reports positive data from PLATINUM Element Stent quantitative coronary angiography study

Aeras and Crucell commence Phase II study of TB vaccine candidate in infants

Redefining control and consistency in anaerobic microbiome workflows

AI in Healthcare: How generative tools are transforming clinical practice

The future of automation: Machine learning–driven hepatocyte and organoid counting

Latest News